Key result
Vasodilator stress echocardiography with CFVR was highly feasible (93.9%), with unfeasibility predicted by resting heart rate ≥77 bpm (OR 2.25) and anterior ischemia (OR 3.14).
Why the study?
Stress echocardiography allows comprehensive assessment of wall-motion abnormalities and Doppler-based CFVR in the LAD, but the variables affecting CFVR detection success were unclear.
What clinical, hemodynamic, and functional variables affect the success rate of coronary flow velocity reserve detection during vasodilator stress echocardiography in patients with known or suspected coronary syndromes?
Observational (n=2,989)
No
What clinical, hemodynamic, and functional variables affect the success rate of coronary flow velocity reserve detection during vasodilator stress echocardiography in patients with known or suspected coronary syndromes?
Vasodilator stress echocardiography with CFVR is highly feasible (93.9%) without contrast, though success is slightly reduced by high resting heart rate, obesity in women, and anterior ischemia.
Identifies factors linked to lower CFVR feasibility; leaves open whether tailored protocols improve detection in coronary syndromes.
AIM: Stress echocardiography (SE) with state-of-the-art imaging protocol allows a comprehensive assessment of regional wall-motion abnormalities and Doppler-based coronary flow velocity reserve (CFVR) in left anterior descending artery (LAD). We sought to assess the variables potentially impacting on success rate of SE with CFVR. METHODS AND RESULTS: In a single-center, prospective, observational study design, from 2007 to 2019, we enrolled 2989 consecutive patients (age 67 ± 12 years; 1723 men) referred for SE, without contrast, for chronic known (n = 1130) or suspected (n = 1859) coronary syndromes. Coronary flow velocity reserve was measured as stress/rest peak diastolic flow velocity. The same operator (LC) performed all examinations with the same machine (GE Vivid 7). Interpretable CFVR was obtained in 2808 patients (feasibility = 93.9%). Overall success rate was lowest (91.4%) in 2007-2008 and steadily rose to 97.8% in 2017-2019 (P for trend <.0001). Feasibility was excellent for men (93.7%) and women (94.3%) (P = .47) across all values of body mass index (BMI): <25 (P = .09), 25-29 (P = .84), and ≥30 (P = .23). At multivariable logistic regression analysis, women with BMI ≥ 30 (OR 1.94, 95% CI 1.14-3.29, P = .02), resting heart rate ≥77 beats/min (OR 2.25, 95% CI 1.64-3.11; P < .0001), and stress-induced ischemia in the LAD territory (OR 3.14, 95% CI 1.67-5.90; P < .0001) predicted unfeasible CFVR. CONCLUSION: Vasodilator SE with CFVR combined with wall-motion analysis is highly feasible also without contrast although with a slight decline in presence of high resting heart rate (reducing diastolic time essential for flow imaging), women with BMI ≥ 30 (increasing tissue thickness interposed between transducer and artery), and anterior ischemia (for underlying low-absent anterograde flow for severely stenotic or occluded LAD).
No takes yet. Share an insight, caveat, or question.
Cortigiani et al. (2020) conducted an observational in Chronic known or suspected coronary syndromes (n=2,989). Vasodilator stress echocardiography with coronary flow velocity reserve (CFVR) was evaluated on Interpretable CFVR (feasibility). Vasodilator stress echocardiography with CFVR was highly feasible (93.9%), with unfeasibility predicted by resting heart rate ≥77 bpm (OR 2.25) and anterior ischemia (OR 3.14).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: